| Su | Mo | Tu | We | Th | Fr | Sa |
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
View:
Quick Links
- Admissions
- Directory
- Experiential Program
- Technology Services
- Pharmacy Library
- Student Affairs
- Office of the Dean
- Central Business Office
Contact
217 Parks Hall
500 West 12th Ave.
Columbus, OH 43210
Phone: (614) 292-2266
Fax: (614) 292-2588
College of Pharmacy News and Events
|
10/1/2009 11:30 AM Biology + Delivery + Pharmacodynamics + Computation = Greater Success in Cancer Drug Development 202 Parks Hall by Jessie L-S Au, PharmD, PhD, Distinguished University Professor, Division of Pharmaceutics. Contact: Dennis B. McKay, Ph.D. 292-3771 Email
| |
|
10/6/2009 3:00 PM ASP Career Fair 2009 Nationwide & Farm Bureau 4H center The Career Expo is an opportunity to network and build rapport with different representatives and companies. All students are encouraged to talk with representatives from the various fields of pharmacy about summer internships and future jobs. Interviews will be arranged for those who are interested. Contact: Career Fair Staff Email Link
| |
|
10/7/2009 11:30 AM MicroRNA-based therapy for pancreatic cancer; Linking anti-proliferative effect to microRNA target genes 250 LM Parks Hall Seminar 850 presented by Jong Kook Park Contact: Jeff Johnston 292-2607 Email File
| |
|
10/7/2009 3:30 PM Medicinal Chemistry & Pharmacognosy Seminar 250 Parks Hall Billy Day, Ph.D., Professor and Director - Proteomics Core Lab, Schools of the Health Sciences: Medicinal Chemistry / Molecular Pharmacology and Toxicology / Proteomics, University of Pittsburgh will presnt a seminar. Title TBA. Contact: James Fuchs 7-7377 Email
| |
|
10/8/2009 11:30 AM H3 Receptor Antagonists: Preclinical Promise for Treating Cognitive Disorders 202 Parks Hall by Tim Esbenshade, Ph.D., Senior Group Leader & Associate Fellow, Neuroscience Research, Abbott Laboratories, Abbott Park, IL. Contact: Dennis B. McKay, Ph.D. 292-3771 Email
| |
|
10/14/2009 11:30 AM Division of Pharmaceutics Seminar 850.01 250 L.M. Parks Hall Ribonucleotide reductase is a novel target of 5-azacytidine in vitro and in vivo Contact: Carol Camm 292-3385 Email File
| |
|
10/17/2009 9:00 AM Pharmacy Day 2009 103 Parks Hall Pharmacy Day is an event for students of every age from high school to college and beyond. Parents and other members of the community are welcome to attend and learn about the exciting profession of pharmacy. Contact: Joe Orozco (614) 688-3772 Email File
| |
|
10/20/2009 4:00 PM "miRNA Expression Profiling in Pancreatic Cancer by nano-scale qPCR: 105 Biomedical Research Tower Special Seminar presented by
Tom Schmittgen, Ph.D.
Associate Professor
College of Pharmacy, OSU
&
John Hudson, Ph.D.
Fluidigm Corporation
South San Francisco, CA
Contact: Thomas Schmittgen 292-3456 Email File
| |
|
10/21/2009 11:30 AM Protein Encapsulated Acetalated Dextran Vaccines for Particulate Immunotherapy 250 LM Parks Hall Seminar 850 presented by Naveen Kathamneni Contact: Jeff Johnston 292-2607 Email File
| |
|
10/21/2009 3:30 PM Medicinal Chemistry & Pharmacognosy Seminar 250 Parks Hall Brian Shoichet, Ph.D., Professor of Pharmaceutical Chemistry, University of Cailfornia, San Francisco will present a seminar. Title TBA. Contact: James Fuchs 7-7377 Email
| |
|
10/22/2009 11:30 AM Expression Genetics: New Approach to Optimizing Drug Therapy 202 Parks Hall by Wolfgang Sadee, Dr.rer.nat, Felts Mercer Professor of Medicine & Pharmacology; Director, Program in Pharmacogenomics, OSU College of Medicine. Contact: Dennis B. McKay, Ph.D. 292-3771 Email
| |
|
10/28/2009 11:30 AM Investigations into the role of aberrantly expressed noncoding RNAs in cancer 250 LM Parks Hall Seminar 850 presented by Ana Azevedo Contact: Jeffrey Johnston, PhD 292-2607 Email File
| |
|
10/29/2009 11:30 AM HTS-ing Towards Functionally Selective Allosteric Modulators of the Dopamine Receptor 202 Parks Hall by R. Benjamin Free, Ph.D., Molecular Neuropharmacology Section, NIH/National Institute of Neurological Diseases & Stroke, Bethesda, MD. Contact: Dennis B. McKay, Ph.D. 292-3771 Email
| |